Head to Head Contrast: St Jude Medical (STJ) versus Its Competitors
St Jude Medical (NYSE: STJ) is one of 19 publicly-traded companies in the “Medical Devices & Implants” industry, but how does it compare to its competitors? We will compare St Jude Medical to similar businesses based on the strength of its institutional ownership, valuation, profitability, earnings, analyst recommendations, dividends and risk.
This is a summary of current ratings and target prices for St Jude Medical and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|St Jude Medical||0||0||0||0||N/A|
|St Jude Medical Competitors||111||729||1026||10||2.50|
As a group, “Medical Devices & Implants” companies have a potential upside of 37.26%. Given St Jude Medical’s competitors higher probable upside, analysts plainly believe St Jude Medical has less favorable growth aspects than its competitors.
Institutional and Insider Ownership
82.7% of St Jude Medical shares are owned by institutional investors. Comparatively, 54.8% of shares of all “Medical Devices & Implants” companies are owned by institutional investors. 4.8% of St Jude Medical shares are owned by company insiders. Comparatively, 10.3% of shares of all “Medical Devices & Implants” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
This table compares St Jude Medical and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|St Jude Medical||14.14%||19.40%||6.75%|
|St Jude Medical Competitors||-101.23%||-92.70%||-30.32%|
Valuation & Earnings
This table compares St Jude Medical and its competitors top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|St Jude Medical||N/A||N/A||35.45|
|St Jude Medical Competitors||$1.67 billion||$207.58 million||76.34|
St Jude Medical’s competitors have higher revenue and earnings than St Jude Medical. St Jude Medical is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
St Jude Medical pays an annual dividend of $1.24 per share and has a dividend yield of 1.5%. St Jude Medical pays out 54.4% of its earnings in the form of a dividend. As a group, “Medical Devices & Implants” companies pay a dividend yield of 1.3% and pay out 39.8% of their earnings in the form of a dividend. St Jude Medical has increased its dividend for 6 consecutive years.
St Jude Medical beats its competitors on 5 of the 9 factors compared.
About St Jude Medical
St. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company’s product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products.
Receive News & Ratings for St Jude Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for St Jude Medical Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.